SCHEMBL4649740

SCHEMBL4649740

CC(=O)c1cc(F)c(Cl)cc1NCC(=O)Nc1ccccc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
KDM4E B2RXH2 2/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 3/20 0.47
MEN1 O00255 3/20 0.47
LMNA P02545 3/20 0.47
NPSR1 Q6W5P4 1/20 0.47
GAA P10253 2/20 0.46
AGER Q15109 1/20 0.44
POLB P06746 1/20 0.43
HTT P42858 2/20 0.43
AVPR2 P30518 1/20 0.43
OXTR P30559 1/20 0.43
AVPR1A P37288 1/20 0.43
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
HPGD P15428 3/20 0.42
ABL1 P00519 1/20 0.42
RIN1 Q13671 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL4695201 0.99 ALDH1A1 (0.49) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4651312 0.95 ALDH1A1 (0.50) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4650280 0.91 KMT2A (0.50) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4650518 0.91 KMT2A (0.50) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4650513 0.90 ALDH1A1 (0.49) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL14201562 0.89 ALDH1A1 (0.58) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4651062 0.87 ALDH1A1 (0.47) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4650312 0.87 ALDH1A1 (0.47) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4650393 0.86 KMT2A (0.46) ALDH1A1KDM4EKMT2AMAPTMEN1
SCHEMBL4650471 0.85 ALDH1A1 (0.47) ALDH1A1KDM4EKMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101336236-A Anthranilic acid derivatives useful in treating infection with hepatitis c virus WYETH CORP (US) 2008-12-31 CN claimed
EP-1966181-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS Wyeth (US) 2008-09-10 EP claimed
WO-2008051244-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-05-02 WO claimed
CN-101336236-A Anthranilic acid derivatives useful in treating infection with hepatitis c virus WYETH CORP (US) 2008-12-31 CN disclosed
EP-1966181-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS Wyeth (US) 2008-09-10 EP disclosed
WO-2008051244-A2 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-05-02 WO disclosed